AC Immune ACIU
NASDAQ ACIU
$2.86 -0.07 (-2.39%)
At close: Sep 4, 2026 · 4:00 PM EDT

AC Immune (ACIU) Long-Term Deferred Tax (2019 - 2026)

Analysis

AC Immune (ACIU) Long-Term Deferred Tax (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 AC Immune 285.13 Mn 285.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.63 Mn
Sep 30, 2024 18,467.32
Jun 30, 2024 49,760.71
Sep 30, 2021 133,962.88
Jun 30, 2021 381,633.20
Mar 31, 2021 641,514.26
Sep 30, 2020 1.17 Mn
Jun 30, 2020 1.46 Mn
Mar 31, 2020 2.53 Mn
Sep 30, 2019 4.77 Mn
Jun 30, 2019 3.93 Mn
Mar 31, 2019 3.56 Mn